Noticias de IMMP_US

Noticias del mercado

Últimas noticias sobre IMMP_US — 190 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IMMP_US ✕ 190 resultados
26/03/2026 IMMP_US — Finansavisen ES ← EN
ALERTA PARA INVERSORES: El bufete de abogados Pomerantz investiga reclamaciones en nombre de los inversores de Immutep Limited - IMMP
26/03/2026 IMMP_US — DirectorsTalk Interviews
Immutep Limited (IMMP) Stock Analysis: Uncovering A Potential 171.74% Upside In Biotech
20/03/2026 IMMP_US — Business Wire
IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm
20/03/2026 IMMP_US — TipRanks
Immutep Advances First-in-Class LAG-3 Agonist IMP761 With Positive Phase I Progress
19/03/2026 IMMP_US — Yahoo Finance
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
19/03/2026 IMMP_US — Stock Titan
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761
19/03/2026 IMMP_US — Stock Titan ES ← EN
Immutep supera la primera etapa de dosificación de un fármaco autoinmune sin problemas de seguridad
19/03/2026 IMMP_US — The West Australian
ASX Runners of the Week: Immutep, Blue Star Helium & Patagonia
19/03/2026 IMMP_US — DirectorsTalk Interviews
Immutep Limited (IMMP) Stock Analysis: Navigating a Potential 140% Upside in the Biotech Sector
18/03/2026 IMMP_US — MarketScreener
Immutep updates market on TACTI-004 and pipeline priorities
18/03/2026 IMMP_US — TipRanks
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761
18/03/2026 IMMP_US — TipRanks
Insignia Financial Ceases to Be Substantial Holder in Immutep After Portfolio Rebalancing
17/03/2026 IMMP_US — FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
16/03/2026 IMMP_US — Stock Titan
[6-K] IMMUTEP Ltd Current Report (Foreign Issuer) | IMMP SEC Filing - Form 6-K
16/03/2026 IMMP_US — GlobeNewswire
Immutep Limited Shareholders Are Encouraged to Reach Out to
16/03/2026 IMMP_US — TipRanks
Immutep Halts Pivotal Lung Cancer Trial After Futility Review, Extends Cash Runway
16/03/2026 IMMP_US — Meyka
Immutep (IMM.AX) drops to A$0.061 16 Mar 2026: heavy volume signals reprice
14/03/2026 IMMP_US — Medical Dialogues
Dr Reddy's Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer Study
13/03/2026 IMMP_US — Stock Titan
Immutep trial deemed futile, sees cash runway extending past Q2 2027
13/03/2026 IMMP_US — Investing.com
Immutep stock plunges 80% after lung cancer trial halted By Investing.com

Página 8 de 10

keyboard_arrow_up